BROWSE

Related Scientist

Kim, Do-Kyun's photo.

Kim, Do-Kyun
단백질 커뮤니케이션 그룹
more info

ITEM VIEW & DOWNLOAD

Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function

Cited 0 time in webofscience Cited 0 time in scopus
138 Viewed 0 Downloaded
Title
Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function
Author(s)
Yin, Guo Nan; Do-Kyun Kim; Kang, Ji In; Im, Yebin; Dong Sun Lee; Ah-reum Han; Ock, Jiyeon; Choi, Min-Ji; Kwon, Mi-Hye; Limanjaya, Anita; Saet-Byel Jung; Jimin Yang; Kwang Wook Min; Yun, Jeongwon; Koh, Yongjun; Park, Jong-Eun; Hwang, Daehee; Suh, Jun-Kyu; Ryu, Ji-Kan; Ho Min Kim
Publication Date
2022-05
Journal
EXPERIMENTAL AND MOLECULAR MEDICINE, v.54, no.5, pp.626 - 638
Publisher
SPRINGERNATURE
Abstract
Diabetes: Restoring erectile function lost to diabetes A protein that initiates multiple tissue repair processes could offer effective treatment for erectile dysfunction arising from diabetes mellitus. High blood sugar levels can lead to serious damage to nerves and blood vessels, with impaired male sexual function one potential consequence. Guo Nan Yinof the Inha University School of Medicine, Incheon, South Korea, and colleagues have identified a molecular pathway that can be targeted to reverse such damage. They determined that a protein called LRG1 acts on a receptor called LPHN2 to stimulate blood vessel and nerve growth. LPHN2 is highly expressed in the penile tissue of diabetic humans and rodents, and direct injection of LRG1 effectively restored erectile function in mice. The authors hypothesize that this same pathway could also be used for treatments for other diabetic complications, such as chronic wounds. Diabetes mellitus (DM) is a chronic metabolic disorder characterized by inappropriate hyperglycemia, which causes endothelial dysfunction and peripheral neuropathy, ultimately leading to multiple complications. One prevalent complication is diabetic erectile dysfunction (ED), which is more severe and more resistant to treatment than nondiabetic ED. The serum glycoprotein leucine-rich alpha-2-glycoprotein 1 (LRG1) is a modulator of TGF-beta-mediated angiogenesis and has been proposed as a biomarker for a variety of diseases, including DM. Here, we found that the adhesion GPCR latrophilin-2 (LPHN2) is a TGF-beta-independent receptor of LRG1. By interacting with LPHN2, LRG1 promotes both angiogenic and neurotrophic processes in mouse tissue explants under hyperglycemic conditions. Preclinical studies in a diabetic ED mouse model showed that LRG1 administration into the penile tissue, which exhibits significantly increased LPHN2 expression, fully restores erectile function by rescuing vascular and neurological abnormalities. Further investigations revealed that PI3K, AKT, and NF-kappa B p65 constitute the key intracellular signaling pathway of the LRG1/LPHN2 axis, providing important mechanistic insights into LRG1-mediated angiogenesis and nerve regeneration in DM. Our findings suggest that LRG1 can be a potential new therapeutic option for treating aberrant peripheral blood vessels and neuropathy associated with diabetic complications, such as diabetic ED.
URI
https://pr.ibs.re.kr/handle/8788114/11739
DOI
10.1038/s12276-022-00773-5
ISSN
1226-3613
Appears in Collections:
Pioneer Research Center for Biomolecular and Cellular Structure(바이오분자 및 세포구조 연구단) > Protein Communication Group(단백질 커뮤니케이션 그룹) > 1. Journal Papers (저널논문)
Files in This Item:
There are no files associated with this item.

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse